Researchers find molecule that prevents Type 1 diabetes in mice

November 1, 2011

Researchers at the University of Colorado School of Medicine have found a specific molecule that can prevent the development of type 1 diabetes in mice and has a similar effect on human cells from diabetic patients.

The findings, published in the latest edition of The Journal of Immunology, signal a new and promising direction in the fight against along with other like , multiple sclerosis and .

Aaron Michels, MD, an assistant professor of pediatrics and medicine, working with George Eisenbarth., MD, Ph.D., executive director of the Barbara Davis Center for Childhood at the CU School of Medicine, tested a series of molecules before finding one that stopped diabetes from developing in mice bred to get the disease.

"We found that when you put specific molecules into specific structural pockets you can block the formation of diabetes," said Eisenbarth. "We are basically throwing a monkey wrench into the machinery."

The researchers were looking for small molecules capable of occupying pockets along a protein binding groove. Some of the molecules got into these pockets and inhibited the presentation of insulin to while others enhanced it.

Type 1 diabetes is characterized by the body's inability to manufacture insulin because its own immune system is attacking it. The incidence of the disease has doubled in each of the last two decades.

Michels and Eisenbarth found that the compound Glyphosine enhanced insulin presentation and prevented diabetes in mice genetically modified to develop type 1diabetes. It had the same effect on . The mice remained disease-free as long as they received daily injections of the compound. It was not as effective on mice that already had diabetes.

The molecules used in the research were obtained with the assistance of the University of Florida College of Medicine in Gainesville.

"Our role was to screen a large chemical library to identify drug candidates for prevention of type 1 diabetes," said David Ostrov, Ph.D., associate professor of pathology, immunology and laboratory medicine at the University of Florida. "We developed a novel screening method that pinpoints very specific areas of a protein that is genetically associated with type 1 diabetes."

Using a supercomputer, Ostrov's lab ran tests on 139,735 drug candidates to see which were most likely to bind on the four critical pockets of the protein.

"Not only does this provide a new way to change specific immune responses in a manner that is beneficial for diabetes, this shows that we may be able to modify specific immune responses for other autoimmune diseases," Ostrov said. "This is also relevant to cancer and infectious diseases where it would be beneficial to modify specific immune responses rather than in a general way."

Michels said that based on the two and a half year study, it would be feasible to genetically screen individuals likely to develop and begin a therapy regimen using these compounds to prevent the onset of the disease. Right now, doctors can predict who will get type 1diabetes about 90 percent of the time.

"This technique would also apply to other autoimmune disorders like arthritis and celiac disease," Michels said. "The principals are the same."

The next step is to focus specifically on human cells to try and develop new therapies for clinical use. That could be at least five years away.

Explore further: Early research shows dietary supplement may lower risk of developing type 2 diabetes

Related Stories

Early research shows dietary supplement may lower risk of developing type 2 diabetes

September 22, 2011
UCLA researchers demonstrated that an over-the-counter dietary supplement may help inhibit development of insulin resistance and glucose intolerance, conditions that are involved in the development of Type 2 diabetes and ...

Gene therapy stimulates protein that blocks immune attack and prevents Type 1 diabetes in mice

July 6, 2011
Increasing a specific protein in areas of the pancreas that produce insulin blocks the immune attack that causes type 1 diabetes, researchers reported in the August issue of the Journal of Clinical Investigation, published ...

Recommended for you

Team finds link between backup immune defense, mutation seen in Crohn's disease

July 27, 2017
Genes that regulate a cellular recycling system called autophagy are commonly mutated in Crohn's disease patients, though the link between biological housekeeping and inflammatory bowel disease remained a mystery. Now, researchers ...

Study finds harmful protein on acid triggers a life-threatening disease

July 27, 2017
Using an array of modern biochemical and structural biology techniques, researchers from Boston University School of Medicine (BUSM) have begun to unravel the mystery of how acidity influences a small protein called serum ...

CRISPR sheds light on rare pediatric bone marrow failure syndrome

July 27, 2017
Using the gene editing technology CRISPR, scientists have shed light on a rare, sometimes fatal syndrome that causes children to gradually lose the ability to manufacture vital blood cells.

Post-stroke patients reach terra firma with new exosuit technology

July 26, 2017
Upright walking on two legs is a defining trait in humans, enabling them to move very efficiently throughout their environment. This can all change in the blink of an eye when a stroke occurs. In about 80% of patients post-stroke, ...

Molecular hitchhiker on human protein signals tumors to self-destruct

July 24, 2017
Powerful molecules can hitch rides on a plentiful human protein and signal tumors to self-destruct, a team of Vanderbilt University engineers found.

Researchers develop new method to generate human antibodies

July 24, 2017
An international team of scientists has developed a method to rapidly produce specific human antibodies in the laboratory. The technique, which will be described in a paper to be published July 24 in The Journal of Experimental ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.